                         SEQUENCE LISTING

<110>  Fwd Holding ApS
 
<120>  pMHC Multiplexers by addition of MHC2 and rolling circle peptide 
       multimer display

<130>  22982PCT00

<140>  PCT/EP2022/052128
<141>  2022-01-28

<150>  PA202100090
<151>  2021-01-28

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  1

Ala Gln Leu Glu Lys Glu Leu Gln Ala Leu Glu Lys Glu Asn Ala Gln 
1               5                   10                  15      


Leu Glu Trp Glu Leu Gln Ala Leu Glu Lys Glu Leu Ala Gln 
            20                  25                  30  


<210>  2
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  2

Ala Gln Leu Lys Lys Lys Leu Gln Ala Leu Lys Lys Lys Asn Ala Gln 
1               5                   10                  15      


Leu Lys Trp Lys Leu Gln Ala Leu Lys Lys Lys Leu Ala Gln 
            20                  25                  30  


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  3

Ala Gln Leu Glu Lys Glu Leu Gln Ala Leu Glu Lys Glu Asn Ala Gln 
1               5                   10                  15      


Leu Glu Trp Glu Leu Gln Ala Leu Glu Lys Glu Leu Ala Gln Gly Gly 
            20                  25                  30          


Cys 
    


<210>  4
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  4

Ala Gln Leu Lys Lys Lys Leu Gln Ala Leu Lys Lys Lys Asn Ala Gln 
1               5                   10                  15      


Leu Lys Trp Lys Leu Gln Ala Leu Lys Lys Lys Leu Ala Gln Gly Gly 
            20                  25                  30          


Cys 
    


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  5

Met Ser Ile Tyr Val Tyr Ala Leu Pro Leu Lys Met Leu Asn Ile 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  6

Ala Leu Pro Leu Lys Met Leu Asn Ile Pro Ser Ile Asn Val His 
1               5                   10                  15  


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  7

Pro Lys Tyr Val Lys Gln Asn Thr Leu Lys Leu Ala Thr 
1               5                   10              


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  8

Thr Ser Leu Tyr Asn Leu Arg Arg Gly Thr Ala Leu Ala 
1               5                   10              


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  9

Ile Asn Leu Met Lys Leu Pro Leu Ala Tyr Val Tyr Ile Ser Met 
1               5                   10                  15  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  10

Gly Ser Ser Gly Ser Ser Pro Asp Pro Ala 
1               5                   10  


<210>  11
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  11

Met Ser Ile Tyr Val Tyr Ala Leu Pro Leu Lys Met Leu Asn Ile Gly 
1               5                   10                  15      


Ser Ser Gly Ser Ser Pro Asp Pro Ala 
            20                  25  


<210>  12
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence


<220>
<221>  misc_feature
<222>  (7)..(8)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (10)..(11)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (13)..(14)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (19)..(20)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (22)..(23)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (28)..(29)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (31)..(32)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (34)..(35)
<223>  n is a, c, g, or t

<400>  12
gctctgnnkn nknnsgytnn knnsctgnnk nnknnsatgc at                          42


<210>  13
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence


<220>
<221>  misc_feature
<222>  (3)..(5)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa in position 6 = Val or Ala

<220>
<221>  misc_feature
<222>  (7)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (10)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  13

Ala Leu Xaa Xaa Xaa Xaa Xaa Xaa Leu Xaa Xaa Xaa Met His 
1               5                   10                  


<210>  14
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  14
cagccagttg ctctcgaggg acagagcatg cat                                    33


<210>  15
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  15
ggttcacagg cttggtctgc aggctctg                                          28


<210>  16
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  16
ggttcacagg cttggtctgc ag                                                22


<210>  17
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant sequence

<400>  17
cagccagttg ctctcgaggg a                                                 21


